Authors

• David Clayton (ORCID: https://orcid.org/0000-0002-3850-8200)
• Colm Elliott (ORCID: https://orcid.org/0000-0002-3004-523X)
• Licínio Craveiro (ORCID: https://orcid.org/0000-0002-8841-8035)
• Dumitru Fetco (ORCID: https://orcid.org/0000-0003-1335-8274)
• David Araújo (ORCID: https://orcid.org/0000-0002-1600-6138)
• Marco Ganzetti (ORCID: https://orcid.org/0000-0002-7049-171X)
• Sridar Narayanan (ORCID: https://orcid.org/0000-0002-6283-150X)
• Zahra Karimaghaloo
• Douglas Lorne Arnold (ORCID: https://orcid.org/0000-0003-4266-0106)
• David A. Rudko (ORCID: https://orcid.org/0000-0002-1299-954X)
• Agne Kazlauskaite (ORCID: https://orcid.org/0000-0001-9145-8479)
• Ahmed M. Elkady (ORCID: https://orcid.org/0000-0002-6793-3396)

Institutions

• Roche (Switzerland) (CH)
• Montreal Neurological Institute and Hospital (CA)
• NeuroRx Research (Canada) (CA)
• McGill University (CA)

Publication Details

Journal

Journal of Magnetic Resonance Imaging

Published

2024-09-06

DOI

https://doi.org/10.1002/jmri.29583

Citations

5

Primary Topic

Multiple Sclerosis Research Studies

Type

article

Field-Weighted Citation Impact

2.12

Funders

• U.S. Department of Defense
• Mitacs
• Canada First Research Excellence Fund